NMR-Based Metabonomics of Urine from An Exploratory Study of Ciprofibrate in Healthy Volunteers and Patients with Type 2 Diabete
Pp. 175-191 (17)
Gregory C. Leo, Ewoud J. van Hoogdalem and Martijn B.A. van Doorn
This report presents the results from the NMR-based metabonomics of urine collected as part of a multiple dose, double-blind, randomized, placebo controlled parallel group exploratory study of the pharmacodynamics of ciprofibrate in healthy volunteers and patients with type 2 Diabetes Mellitus. Using supervised statistical analysis it was possible to distinguish the various treatment groups (healthy and diabetic: placebo-treated or drug-treated) when males and females were analyzed separately.
Johnson&Johnson Pharmaceutical Research and Development, LLC, Welsh and McKean Roads, Springhouse, PA 19477-0776, USA.